Skip to main content
Erschienen in: Wiener klinische Wochenschrift 21-22/2023

Open Access 02.08.2023 | review article

Vibrio cholerae—An emerging pathogen in Austrian bathing waters?

verfasst von: Carmen Rehm, Claudia Kolm, Sonja Pleininger, Florian Heger, Alexander Indra, Georg H. Reischer, Andreas A. H. Farnleitner, Alexander K. T. Kirschner

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 21-22/2023

Summary

Vibrio cholerae, an important human pathogen, is naturally occurring in specific aquatic ecosystems. With very few exceptions, only the cholera-toxigenic strains belonging to the serogroups O1 and O139 are responsible for severe cholera outbreaks with epidemic or pandemic potential. All other nontoxigenic, non-O1/non-O139 V. cholerae (NTVC) strains may cause various other diseases, such as mild to severe infections of the ears, of the gastrointestinal and urinary tracts as well as wound and bloodstream infections. Older, immunocompromised people and patients with specific preconditions have an elevated risk. In recent years, worldwide reports demonstrated that NTVC infections are on the rise, caused amongst others by elevated water temperatures due to global warming.
The aim of this review is to summarize the knowledge gained during the past two decades on V. cholerae infections and its occurrence in bathing waters in Austria, with a special focus on the lake Neusiedler See. We investigated whether NTVC infections have increased and which specific environmental conditions favor the occurrence of NTVC. We present an overview of state of the art methods that are currently available for clinical and environmental diagnostics. A preliminary public health risk assessment concerning NTVC infections related to the Neusiedler See was established. In order to raise awareness of healthcare professionals for NTVC infections, typical symptoms, possible treatment options and the antibiotic resistance status of Austrian NTVC isolates are discussed.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Vibrio cholerae is a natural inhabitant of aquatic ecosystems and is known as one of the most important waterborne human pathogens [1]. The bacterium was originally discovered by Filippo Pacini in 1854 and confirmed 30 years later by Robert Koch, who first was able to grow a pure culture [2]. It was described as curved, comma-shaped and highly movable due to its polar flagellum [3]. This gram-negative bacterial species consists of a large number of genetically and phenotypically different strains and biotypes, which are further classified into more than 200 serogroups, based on the lipopolysaccharide O‑antigen [4]. Its full genome consisting of two chromosomes was first sequenced in the year 2000 [5].

The disease cholera

So far, only strains belonging to the serogroups O1 and O139 (with a few exceptions [6, 7]) carry the pathogenicity factors ctx and tcp required to cause epidemic or even pandemic cholera outbreaks [1]. Ctx encodes for the cholera toxin, responsible for causing the devastating diarrheal disease cholera and is encoded on the filamentous phage ctxPhi [8]. The factor tcp is located in the Vibrio pathogenicity island (vpi1) and codes for the toxin co-regulated pilus. This pilus acts as an adhesion factor for ctxPhi carrying the cholera toxin gene and also facilitates the colonization of the epithelial surface in the intestine [9]. Cholera infections are characterized by a typical rice-water stool and a severe loss of fluids of up to 20 l per day with a high mortality of up to 50% if untreated, due to severe dehydration [10]. Treatment with appropriate rehydration medium [11, 12] as part of an effective case management reduces the mortality to less than 1% [13]. The primary infection route is via ingestion of (drinking) water resources with naturally occurring, endemic V. cholerae O1/O139. The further spread of the disease occurs via contaminated water or food as well as via person to person contact, primarily in areas lacking safe water supplies (fecal-oral transmission route) [14]. In addition to control water and sanitation, vaccines are used for prevention in areas that are at high risk for cholera infections [15]. According to the World Health Organization (WHO), researchers have estimated that each year there are 1.3–4.0 million cases of cholera, and 21,000–143,000 deaths worldwide [12, 16].
Major ongoing cholera outbreaks have been reported from several countries in Africa and Asia in 2022 [17]. In contrast, cholera infections hardly ever occur in Europe and in all cases there is a connection to travelling to cholera endemic areas. In 2022, there were three documented cases in Europe [18], whilst the latest cases in Austria were in 2013, 2018 and 2022 which were reported to the ECDC via the European Surveillance System (TESSy). The exception to travel-related cholera was an accidental laboratory-induced cholera infection of a microbiology student in Austria in 2008 [19]. In general, tourists are at very low risk of infection because certain factors, such as the socioeconomic status influencing nutrition and gut microbiome and the type of travel, play an important role in the manifestation of the disease [14]. The risk of transmission within European countries is extremely low due to high sanitation and hygiene standards.

Nontoxigenic Vibrio cholerae (NTVC) as a pathogenic agent

In contrast to cholera-toxigenic V. cholerae O1/O139, nontoxigenic, non-O1/non-O139 strains are present worldwide in specific aquatic environments and are able to cause different types of infections [20].
Pathogenicity and clinical manifestation
Nontoxigenic Vibrio cholerae (NTVC) strains possess a variety of pathogenicity factors (Table 1), enabling the pathogen to cause a wide range of diseases [21]. In addition to gastrointestinal infections, infections of ears, wounds and bloodstream (bacteremia, septicemia) are the most frequently reported [20, 22, 23]. Sporadic cases of necrotizing fasciitis [24], meningitis [25], and keratitis [26] have also been reported. Patients suffering from a gastrointestinal infections may have abdominal cramps, nausea and fever in addition to the main symptom diarrhea [27]. Ear infections are mostly manifested as otitis externa [28], or even as chronic otitis media [29]. Due to the high growth rate of the pathogen, wound infections can spread rapidly and lead to necrosis of the surrounding tissue (e.g. in the case of necrotizing fasciitis [24]) or septicemia with multiple organ failure [30], specifically in predisposed or immunocompromised individuals [23, 31]. In the majority of cases, the clinical presentation in healthy individuals is mild. Especially very young or older, immunocompromised patients or patients with chronic diseases (such as diabetes mellitus, hepatic disease, renal insufficiency, cardiovascular diseases) are at increased risk [23, 31].
Table 1
Overview of the most important pathogenicity factors found in V. cholerae
Pathogenicity factor
Abbreviation
Mechanism of pathogenicity
Source
Accessory cholera enteroxin
Ace
Increase of transcellular ion transport trough activation of chloride channels resulting in increase of fluid secretion (diarrhea)
[94]
Choleratoxin subunit a
ctxA
Cholera toxin consists of two subunits (subunit a is combined with max. five subunits b). Subunit a is responsible for intracellular toxicity resulting in massive diarrhea and dehydration
[95]
Choleratoxin subunit b
ctxB
Subunit b binds to a cell surface receptor, which facilitates the transmembrane transport leading to subsequent insertion of the toxin
[95]
Zonula occludens toxin
Zot
Decrease of intestinal tissue resistance/increase of intestinal permeability due to modification of intercellular tight junctions
[96]
Toxin-coregulated pilus
tcpA
Adhesion factor for the phage carrying the cholera toxin gene.
Facilitation of the colonization of the epithelial surface in the intestine
[8]
Cholix toxin A
chxA
Required for infection of eukaryotes by receptor-mediated endocytosis, translocation to the host cytoplasm, and inhibition of protein synthesis
[97]
Hemolysin A
hlyA
Responsible for lysis of red blood cells
[98]
Motility-associated killing factor A
makA
Pore-forming toxin that promotes endocytosis in host cells
[99]
Mannose-sensitive hemagglutinin
mshA
Adhesion factor for attachment of V. cholerae to zooplankton and biofilm formation
[100]
Outer membrane protein U
ompU
Adhesion factor involved in cholera pathogenesis
[101]
Outer membrane protein T
ompT
Pore-forming toxin that provides transport of hydrophilic solutes through the outer membrane
[102]
Repeats in toxin A
rtxA
Plays an important role in cellular rounding and depolymerization of the actin cytoskeleton in host cells
[103]
Heat stable enterotoxin
Stn/sto
Causing severe diarrhea comparable to clinical cholera symptoms
[104]
Toxin regulator R
toxR
Activation of transcription of several virulence genes (e.g. toxT, ompU, ompT)
[105]
Toxin regulator T
toxT
Direct transcriptional activator of ctx and tcp
[106]
Type III secretion system
T3SS
Causes alteration of actin polymerization homeostasis, required for efficient intestinal colonization
[107]
Type VI secretion system
T6SS
Can translocate effector proteins into macrophages and covalently cross-link actin in vitro
[108]
Up to now, there is only limited information on the association of specific virulence factors with specific infection types. In a comparative study of German and Austrian isolates it was found that non-O1, non-O139 strains from patients with diarrheal symptoms possessed the type III secretions system (T3SS) and/or the multifunctional autoprocessing repeats-in-toxin (MARTX) toxin, which were not found in the strains associated with ear or wound infections [32]. Whether this is globally the case, remains to be investigated. Also, clinical isolates exhibit similar virulence gene profiles as environmental ones. It was thus concluded that many virulence traits of V. cholerae have evolved in response to biotic and abiotic pressure and serve adaptation purposes in the natural aquatic environment, at the same time as providing a prerequisite for infection of susceptible human hosts [21].
Treatment and antibiotic resistance
In most cases, diarrhea caused by NTVC is harmless and self-limiting. Generally, people with a gastrointestinal infection should recover within a few days [23]; however, antibiotic treatment is recommended for severe cases of diarrhea. Antibiotics are also the treatment of choice in cases of severe or prolonged ear infections, wound infections, septicemia or necrotizing fasciitis. Due to the high growth rate of the pathogen, rapid decisions based on antimicrobial susceptibility testing of the isolated pathogen are necessary to prevent severe outcomes, such as amputation of limbs or death, specifically with septicemia and necrotizing fasciitis. The first choice of antibiotics is doxycycline or ciprofloxacin (in case of gastrointestinal infections). For severe infections and septicemia, third generation cephalosporins should be added [33]. Previous studies on Austrian environmental isolates showed high proportions of antimicrobial resistance to sulfonamides (97.5%) and streptomycin (39%, [34]). Resistances to ampicillin were also observed in up to 21% of the investigated isolates. Clinical isolates from patients who were in contact with the same environments displayed similar resistance patterns, but some of them were additionally resistant to amoxicillin/clavulanic acid [34], the most widely used broad spectrum antibiotic. No resistances were found against all recommended first-line (see above) and last-line treatment options (4th generation cephalosporins, carbapenems). Similar results were observed in France, with resistances to streptomycin (22%), sulfonamides (44%) and ampicillin (9%) [35]. In German coastal samples of the North Sea and the Baltic Sea, some sporadic isolates with resistance to carbapenems, quinolones and folate pathway inhibitors were found [36]. Low resistance levels were also observed among 307 NTVC isolates from Chesapeake Bay, USA. Only 13% carried a phenotypic resistance to ampicillin or penicillin, one isolate was resistant to erythromycin [37]. Sulfonamides were only tested in combination with trimethoprim and did not show resistance for this combined treatment [37], as also observed in the Austrian and French studies [34, 35]. In contrast, in cholera epidemic countries, resistances to macrolides (erythromycin), fluoroquinolones (ciprofloxacin), trimethoprim/sulfamethoxazole and tetracycline have been reported with increasing trends for fluoroquinolones (ciprofloxacin, norfloxacin), quinolones (nalidixic acid) and aminoglycosides (gentamicin) [38]. Also, the presence of extended spectrum beta-lactamases (ESBLs) and carbapenemases were reported in some isolates [39]. Therefore, an antibiogram is absolutely mandatory for imported/travel-associated cases.

Environmental reservoirs and transmission to humans

NTVC are natural inhabitants of marine and inland waters with mostly light to moderate salinity [20]. In countries with good sanitary and water hygiene conditions, NTVC thus do not enter a natural water body through human fecal pollution and there is no possibility of preventing their growth in suitable aquatic environments. Transmission to humans most frequently occurs via consumption of seafood or direct contact with water during recreation, such as bathing, swimming or water sports [20]. Besides salinity, different environmental parameters, such as organic and inorganic nutrients, pH, or biological interactions with plankton species are known to influence the occurrence of NTVC [4042]. Specifically, V. cholerae has a high affinity for attachment to and colonization of chitin surfaces, such as zooplankton, which are considered as the main environmental reservoir [43]. The exoskeleton surface of a single colonized crustacean zooplankton individual has been shown to contain up to 104V. cholerae cells [44], which may have an impact on the likelihood of acquiring a gastrointestinal infection. In this way, zooplankton might act as “Trojan horses”, protecting V. cholerae during the gastric passage. The biofilm mode of life and interaction with zooplankton also enhances the natural competence for DNA uptake by transformation or horizontal gene transfer from neighboring V. cholerae cells and other bacterial species [45]. In this way, NTVCs obtain an evolutionary advantage by achieving a better adaptation to changing environments, including the acquisition of antibiotic resistance genes or new pathogenic traits [45]. Other environmental hosts of V. cholerae that may also act as potential transmission vehicles are egg masses of chironomids [46], fish [47] and waterfowl [48]. Interaction of V. cholerae was also reported with amoeba (such as Acantamoeba castellanii or Tetrahymea pyriformis), where the bacteria may escape digestion in food vacuoles and become hyperinfectious [49].

Role of increasing water temperatures due to global warming

Temperature was identified as one of the main factors impacting the growth of environmental V. cholerae [20]. V. cholerae is very sensitive to cold temperatures (below 10–15 °C), where they enter the so-called VBNC (viable, but non-culturable) state, resulting in cell size reduction, reduced cell metabolism and cessation of cell division [50]. In the environment, an increase in temperature and the restoration of favorable conditions leads to a resuscitation of the VBNC cells, which also regain their normal phenotypic features [51].
On a global scale, temperatures have increased by approximately 1.1 °C since the late nineteenth century due to global warming [52]. For surface waters in specific regions, the average increase is even higher. For instance, the North Atlantic and North Sea experienced a 1.5 °C rise [53] while the Neusiedler See recorded a remarkable 1.9 °C increase in summer maximum water temperatures per decade over the past 50 years [54]. These observations indicate a high potential for an increase in summer concentrations and latitudinal expansion of suitable areas for V. cholerae [20, 55]. Ongoing warming of coastal regions and reduced salinity (caused by severe precipitation events) are expected to further support the spread of these bacteria on a global scale, especially in northern latitudes [20]. In fact, it has already been observed that plankton-associated Vibrio species (including V. cholerae) have significantly increased in their relative abundance in many oceans of the Northern Hemisphere, which is linked to increased sea-surface temperatures [53, 56, 57]. Consequently, Vibrio species were designated as barometers of climate change [58]. Higher water temperatures triggered by global warming were also linked to the observed increased numbers of infections with V. cholerae and other Vibrio species in the Baltic Sea, specifically during summer heat waves [59, 60]; however, to date no evidence exists whether the observed increased infection numbers were caused by higher Vibrio concentrations in the water or by a higher exposure of an increased number of recreating people. A considerably robust database (COVIS) providing evidence for increasing numbers of V. cholerae and other Vibrio infections is available for the USA [61]. For Europe or other regions in the world, no such databases exist.

Epidemiology of NTVC in Austria

In recent years, several cases of NTVC infections have been documented in Austria with a local history, specifically associated with recreational activities at bathing sites. Before 2005, a total of 5 cases were reported with a definitive association with Lake Neusiedler See, a large subsaline shallow lake in Eastern Austria. Among these, three cases of otitis media, one case of otitis externa and one fatal case of septicemia were reported [28]. In addition, 5 cases of travel history abroad (all diarrhea) and 3 cases of unknown local travel history (all otitis media) were observed [28]. Since 2006, a total of 42 V. cholerae infections have been documented in Austria. Out of these cases, four cases were excluded from the dataset, which were identified as V. cholerae O1 infection. Thus, in total 27 NTVC infections that were most likely (n = 14) or likely (n = 13) acquired in Austria were reported, whilst the rest (n = 11) were imported infections from foreign countries (Fig. 1). In general, no increasing trend or any other pattern could be observed. In fact, most cases occurred in 2015, which was the second warmest year in this country since the beginning of records. During the summer heat wave in 2015, two severe cases of necrotizing fasciitis occurred at two bathing ponds south of Vienna (Eastern Austria), one with fatal outcome [24]. All other cases with a known travel history in Austria were associated with Lake Neusiedler See. Infections regarding the categories “Austria” and “most likely Austria” occurred in patients aged 4–80 years, while the majority of patients were between 4 and 30 years old (40%) or between 51 and 80 years old (29%); only 6% of the patients were between 31 and 50 years old, no age information was available for 25% of the patients (Fig. 2a). Regarding the type of infection, ear infections were the most frequent type, followed by gastrointestinal infections. Urinary tract infections and wound infections (necrotizing fasciitis) occurred two times each (Fig. 2b).
Beyond that, it is anticipated that a considerable number of NTVC infections remain unreported, due to the absence of mandatory reporting requirements. Infections are mostly either mild and self-limiting or they can be treated easily with broad spectrum antibiotics without the need for isolation of NTVC as the causative agent. In addition, physicians are often unaware of NTVC as potential pathogens and thus NTVC infections remain underdiagnosed. In contrast to other regions in the world (see above), no increase in cases has been observed during the past two decades, and severe manifestations of the disease (such as necrotizing fasciitis or septicemia) still appear to be a very rare phenomenon.

Diagnostic methods for NTVC in clinical samples

If an infection caused by NTVCs is suspected, patient samples are taken based on the clinical manifestation. Bacteria can be cultured on sheep blood agar and thiosulfate citrate bile sucrose (TCBS) agar from stool or blood samples, wound or ear swabs. The selective agar TCBS allows a suppression of most other bacteria and a differentiation of Vibrio species based on color of the colonies. Typical colonies (Fig. 3) have to be selected and confirmed by various identification methods such as matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) [62], analytical profile index (API) [63], multiplex PCR [64] or whole genome sequencing (WGS) [65]. While MALDI-TOF is a quick and cheap method, reliable identification is sometimes difficult, as differentiation from sister species such as V. mimicus [66], V. metoecus [67] and the recently described V. paracholerae [68] is hampered by incomplete data bases. In some data bases, V. cholerae isolates are indicated as V. albensis, which was formerly recognized as a separate species but was later integrated into V. cholerae (a non-O1/non-O139 serogroup [69]). As the NTVC populations show a very high genetic [70, 71] and phenotypic diversity [72], multiplex PCR and API methods can also be prone to misidentification when primer target sequences and metabolic properties show variations. The WGS is thus the most reliable method for species identification of NTVC, but comes with elevated costs. After identification of the isolate, simple serotyping with O1 and O139 agglutination sera is usually performed to quickly identify the toxigenic serogroups O1 and O139 [73]. Testing for other serogroups [4] is generally not performed in clinical practice. Furthermore, in severe or imported cases, an antibiogram has to be prepared to assess potential resistances [6]. Following the application of pulsed field gel electrophoresis (PFGE, [74]), ribotyping [75], amplified fragment length polymorphism (AFLP, [76]) and enterobacterial intergenic consensus sequence-PCR (ERIC-PCR, [77]) in the past three decades, current state of the art methods used for strain typing are multi-locus sequence typing (MLST) using a set of 7 housekeeping genes ([78], https://​pubmlst.​org/​organisms/​vibrio-cholerae) or core-genome MLST (cg-MLST) via WGS [79]. When applying WGS for identification and typing, pathogenicity factors and resistance genes can also be concomitantly identified.

Diagnostic methods for NTVC in environmental samples

Cultivation
To assess the occurrence and abundance of NTVC in natural bathing waters, a cultivation-based standard most probable number approach adopted from the detection of this pathogen in foodstuffs is available [80]; however, this approach is highly elaborate and afflicted with a high degree of measurement uncertainty, specifically when quantitative results are needed. Thus, a membrane filtration approach for reliable quantification and a simple direct plating approach for rapid screening was recommended [64]. These approaches have been successfully applied for various bathing waters in Eastern Austria and Serbia [64, 81]. Briefly, for membrane filtration water samples are filtrated in different dilutions (e.g. from 100 ml to 0.1 ml) through 0.45 µm pore size nitrocellulose membrane filters and placed on selective agar plates (TCBS; Fig. 3). For direct plating, 500 µl water are directly streaked on predried TCBS agar plates. After incubation for 18–24 h at 37 °C, the typical presumptive colonies (~2 mm diameter, yellow, round shape) are counted and 5–10 representative colonies per sample are transferred to Columbia Agar without NaCl and incubated for another 24 h. Presumptive V. cholerae isolates grown on agar without NaCl may then be confirmed using multiplex-PCR or MALDI-TOF ([64]; see also above).
Cultivation independent methods
Alternative cultivation-independent methods that have been developed and applied in recent years are based on quantitative PCR (qPCR) and fluorescence microscopy in combination with solid-phase cytometry (SPC). In our laboratory, a triplex qPCR has been developed to simultaneously quantify toxigenic and non-toxigenic V. cholerae in environmental water samples [82, 83]. This method has been modified recently concerning sample concentration and DNA extraction and applied in Serbian lakes and ponds [81]. Briefly, 50–200 ml water samples are filtered onto 0.2 μm pore size polycarbonate filters, followed by phenol-chloroform DNA extraction [84]. Aliquots of the DNA extracts are used for the multiplex qPCR targeting both cholera-toxigenic (ctxA) and non-toxigenic V. cholerae (outer membrane protein W, ompW, a protein that is present in all V. cholerae strains [85]). In addition, an internal amplification control is included in the triplex qPCR assay to indicate potential PCR inhibition.
A highly sensitive microscopic quantification method was also developed, based on the specific staining of V. cholerae cells via fluorescence in-situ hybridization (FISH) combined with catalyzed reporter deposition (CARD) and the detection of the stained cells with a solid phase cytometer (SPC) combined with a fluorescence microscope. This staining technique is based on specific genetic probes that allow identifying and quantifying specific microorganisms with low ribosome content. In CARD-FISH, the RNA-targeted probe is labelled with horseradish peroxidase, to enzymatically increase weak fluorescence signals. In combination with SPC it was possible to quantify V. cholerae cells in the Lake Neusiedler See and its adjacent soda pools year-round, even at very low cell numbers in winter [42, 86]. A disadvantage of the method is that it is highly elaborate and can only be performed in specialized laboratories.

NTVC in Eastern Austrian lakes and ponds

Lake Neusiedler See and adjacent soda pools as hotspots of NTVC
The occurrence of infections caused by NTVC related to recreational activities in Austria was first reported at the beginning of this century for Lake Neusiedler See [28]. Based on these reports, investigations were initiated to study the prevalence of NTVC in this lake. These cultivation-based qualitative investigations illustrated that culturable NTVC were present during the warmer seasons (from May to September) and that their growth was mainly dependent on the temperature and the amount and composition of organic matter [41]. Higher concentrations of humic substances, as they occur in the broad reed stand of the lake inhibited the growth of these pathogens. The limnological characteristics of Neusiedler See (high pH-value around 8.8, electrical conductivity around 2 mS/cm, high nutrient concentrations and high water temperatures above 28 °C at the water surface), offer ideal conditions for the bacteria. The bacteria can either grow in a planktonic state in the water or in biofilms on the surfaces of a specific Cladoceran zooplankton species, Diaphanosoma mongolianum [44]. With the developed cell-based method, cell counts of up to 7.7 × 105 per zooplankton individual were observed [44].
During a 2-year seasonal study at the Neusiedler See and three adjacent small highly saline soda pools (Salzlacken) V. cholerae abundances up to 5.5 × 105 cells L−1 were recorded in the lake water and up to 1.2 × 106 cells L−1 on zooplankton (Fig. 4); however, the zooplankton was a relevant source of V. cholerae only during a short period in late summer. Also resuspended sediment can act as a source of V. cholerae in the water body; up to 104V. cholerae per g sediment were observed [42]. In the soda pools, numbers up to 56 × 106V. cholerae cells per L were recorded, representing (by tenfold) the highest concentrations observed so far for other ecosystems worldwide [42]. Interestingly, an infection with V. cholerae in Neusiedler See was also reported during the cold season (end of November), when no culturable V. cholerae are present [28]. With the developed CARD-FISH SPC method, V. cholerae cells could also be detected at low concentrations during the winter season, where they obviously survive in the viable but non-culturable (VBNC) state [42] and may regain their infectivity after resuscitation in a suitable host.
The diversity of the NTVC strains in Neusiedler See was assessed via multi-locus sequence analysis (MLSA). A total of 472 isolates were collected from water and zooplankton over a time span of 2 years, leading to the identification of 94 different sequence types [70]. The highest diversity was observed in the reed habitat with 71 unique phylogenetic lineages, whereas only 2 unique sequence types were found in the open water habitat. Interestingly, two clinical isolates from patients who were infected in 2008 and 2009, had identical sequences as strains isolated from the lake in 2011 and 2012, suggesting the long-term survival of specific clones within the lake. Even more interesting, a comparison with isolates from several European countries revealed that many NTVC isolates from Sweden, France, Romania and The Netherlands were genetically related to the strains present in the lake belonging to statistically supported monophyletic clades [70]. This phenomenon can be explained by the long-distance transfer of strains, likely facilitated by birds and/or humans. The Neusiedler See along with its adjacent soda pools therefore serve as bioreactors for the emergence of new strains with potentially new (pathogenic) properties.
Preliminary public health risk assessment for Lake Neusiedler See
Due to the facts that (i) no dose-response relationships for NTVC regarding intestinal and extraintestinal infections exist and that (ii) the responsible pathogenicity factors for these infections are not known, no state of the art quantitative risk assessment [8789] can be performed. Thus, a preliminary risk assessment was performed for Lake Neusiedler See [42], based on the available NTVC abundance data, genotyping results from the multiplex PCR and reported minimum infectious doses for V. cholerae (oral exposition mode).
  • Risk of acquiring cholera: during all years, not a single ctx and tcp positive V. cholerae O1/O139 isolate was found and not a single sample yielded a positive ctx signal by qPCR. Thus, the presence of any cholera-causing strains in Neusiedler See can be practically excluded.
  • Risk of acquiring a gastrointestinal infection by NTVC: in the last 20 years, gastrointestinal infections (GI) caused by NTVC in connection with Neusiedler See were reported only rarely (5 cases documented). NTVC concentrations of 5.5 × 105 cells per L lake water were observed. Adopting an infective dose of 105–106 cells from studies with healthy volunteers [9092] one would have to swallow ∼200 ml–2 L of water to acquire a gastrointestinal infection. The presence of zooplankton might significantly lower the amount of water to be swallowed as these small animals can harbour up to 7.7 × 105V. cholerae cells per individual in specific periods of the year [44]. Thus, for susceptible individuals, a few zooplankton organisms may be sufficient for infection.
  • Risk of acquiring a wound or ear infection by NTVC: there are no studies concerning the infective dose for ear or wound infections by NTVC, but it can be assumed that it may be only a few cells, based on exponential single-hit models for other pathogens [93]. Based on available epidemiological data, the number of severe infections is low and has only been reported three times for Austria [24]. Worldwide, severe infections have primarily been associated with vulnerable individuals with specific preconditions (such as immunodeficiency, cancer therapy, skin diseases, liver cirrhosis) placing them at an elevated risk. A significant number of unreported cases may be assumed in healthy individuals, as most of the ear or wound infections are self-limiting or easily treatable with broad spectrum antibiotics. To date, the Austrian NTVC strains do not harbor relevant antibiotic resistance traits against first-line and last-line antibiotics [34].
NTVC in other bathing waters in Eastern Austria
Due to the fact that in 2015, two extreme cases of necrotizing fasciitis were recorded in association with two ponds in Eastern Austria [24], a follow-up study to monitor the occurrence of NTVC in selected bathing ponds in Eastern Austria (Burgenland, Vienna, Lower Austria) was initiated. The NTVC abundance was monitored at 36 bathing sites by culture-based methods. Membrane filtration yielded the most reliable and sensitive results and allowed NTVC detection at 22 sites with concentrations up to 3.9 × 105 CFU per L, all belonging to serogroups other than O1 and O139 and not coding for ctx or tcp [64]. This study showed that NTVC are more widespread in Eastern Austria than previously thought and that more detailed follow-up investigations are necessary to identify the key factors responsible for the occurrence of NTVC in Eastern Austrian bathing waters.
So far, NTVC was only detected in the most eastern Austrian lakes and ponds. In the more western lakes situated at mountainous or alpine altitudes, the occurrence of NTVC is unlikely, due to the different ecological conditions (lower conductivity, lower DOC content, lower summer temperatures in comparison to Eastern Austrian waters).

Conclusion

NTVC infections are still rare in Austria. So far, reported domestic cases have only been linked to bathing waters in Eastern Austria, predominantly to Lake Neusiedler See. In this study, we did not find any evidence indicating a correlation between the increase in bathing water temperatures and a rise in reported NTVC infections over the past two decades. A specific situation was experienced in the heat wave summer of 2015, when a higher number of cases including two severe cases of necrotizing fasciitis (one with fatal outcome) were recorded. These cases were linked to two ponds in Lower Austria; however, in other heat wave summers (such as in 2003, 2012, 2017–2019) no such accumulation of cases was observed. Thus, despite the well-documented rise in V. cholerae infections due to global warming in other regions of the world (USA, Baltic Sea), such a scenario is still unclear for Austria.
Due to the high diversity of NTVC strains, various pathogenicity factors and varying host susceptibility, different kinds of infections can be caused by NTVC. As many of these infections proceed in a self-limiting way or are cured after the use of broad spectrum antibiotics, a substantial number of undiagnosed infections can be assumed. Generally, healthy individuals are not at risk of suffering or experiencing severe infections, but older persons with severe pre-existing illnesses and an immunocompromised status are at elevated risk and should be aware of this fact when recreating in waters with high NTVC concentrations. In cases of infections, due to the high growth rate of the pathogens, rapid antibiotic treatment is recommended, with first-line treatment options of ciprofloxacin, doxycycline and third-generation cephalosporins. In the case of a travel-associated NTVC infection, multidrug resistance is possible and an antibiogram should be conducted as soon as possible to guide appropriate treatment decisions.

Acknowledgements

The study was financed by the Gesellschaft für Forschungsförderung Niederösterreich (GFF), project number LSC17-007. We thank Hans-Peter Hutter for encouraging to conceive and write this paper.

Conflict of interest

C. Rehm, C. Kolm, S. Pleininger, F. Heger, A. Indra, G.H. Reischer, A.H. Farnleitner and A.K.T. Kirschner declare that they have no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

Abo für kostenpflichtige Inhalte

Literatur
1.
Zurück zum Zitat Colwell RR. Infectious disease and environment: cholera as a paradigm for waterborne disease. Int Microbiol. 2004;7:285–9.PubMed Colwell RR. Infectious disease and environment: cholera as a paradigm for waterborne disease. Int Microbiol. 2004;7:285–9.PubMed
3.
Zurück zum Zitat Kojima S, Yamamoto K, Kawagishi I, Homma M. The polar flagellar motor of Vibrio cholerae is driven by an Na+ motive force. J Bacteriol. 1999;181:1927–30.PubMedPubMedCentral Kojima S, Yamamoto K, Kawagishi I, Homma M. The polar flagellar motor of Vibrio cholerae is driven by an Na+ motive force. J Bacteriol. 1999;181:1927–30.PubMedPubMedCentral
4.
Zurück zum Zitat Shimada T, Arakawa E, Itoh K, Okitsu T, Matsushima A, Asai Y, Yamai S, Nakazato T, Nair GB, Albert MJ, Takeda Y. Extended serotyping scheme for Vibrio cholerae. Curr Microbiol. 1994;28:175–8. Shimada T, Arakawa E, Itoh K, Okitsu T, Matsushima A, Asai Y, Yamai S, Nakazato T, Nair GB, Albert MJ, Takeda Y. Extended serotyping scheme for Vibrio cholerae. Curr Microbiol. 1994;28:175–8.
5.
Zurück zum Zitat Heidelberg JF, Eisen JA, Nelson WC, Clayton RA, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Umayam L, Gill SR, Nelson KE, Read TD, Tettelin H, Richardson D, Ermolaeva MD, Vamathevan J, Bass S, Qin H, Dragoi I, Sellers P, McDonald L, Utterback T, Fleishmann RD, Nierman WC, White O, Salzberg SL, Smith HO, Colwell RR, Mekalanos JJ, Venter JC, Fraser CM. DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature. 2000;406:477–83.PubMedPubMedCentral Heidelberg JF, Eisen JA, Nelson WC, Clayton RA, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Umayam L, Gill SR, Nelson KE, Read TD, Tettelin H, Richardson D, Ermolaeva MD, Vamathevan J, Bass S, Qin H, Dragoi I, Sellers P, McDonald L, Utterback T, Fleishmann RD, Nierman WC, White O, Salzberg SL, Smith HO, Colwell RR, Mekalanos JJ, Venter JC, Fraser CM. DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature. 2000;406:477–83.PubMedPubMedCentral
6.
Zurück zum Zitat Tobin-D’Angelo M, Smith AR, Bulens SN, Thomas S, Hodel M, Izumiya H, Arakawa E, Morita M, Watanabe H, Marin C, Parsons MB, Greene K, Cooper K, Haydel D, Bopp C, Yu P, Mintz E. Severe diarrhea caused by cholera toxin-producing vibrio cholerae serogroup O75 infections acquired in the southeastern United States. Clin Infect Dis. 2008;47:1035–40.PubMed Tobin-D’Angelo M, Smith AR, Bulens SN, Thomas S, Hodel M, Izumiya H, Arakawa E, Morita M, Watanabe H, Marin C, Parsons MB, Greene K, Cooper K, Haydel D, Bopp C, Yu P, Mintz E. Severe diarrhea caused by cholera toxin-producing vibrio cholerae serogroup O75 infections acquired in the southeastern United States. Clin Infect Dis. 2008;47:1035–40.PubMed
7.
Zurück zum Zitat Haley BJ, Choi SY, Grim CJ, Onifade TJ, Cinar HN, Tall BD, Taviani E, Hasan NA, Abdullah AH, Carter L, Sahu SN, Kothary MH, Chen A, Baker R, Hutchinson R, Blackmore C, Cebula TA, Huq A, Colwell RR. Genomic and phenotypic characterization of Vibrio cholerae non-O1 isolates from a US gulf coast cholera outbreak. PLoS One. 2014;9:e86264.PubMedPubMedCentral Haley BJ, Choi SY, Grim CJ, Onifade TJ, Cinar HN, Tall BD, Taviani E, Hasan NA, Abdullah AH, Carter L, Sahu SN, Kothary MH, Chen A, Baker R, Hutchinson R, Blackmore C, Cebula TA, Huq A, Colwell RR. Genomic and phenotypic characterization of Vibrio cholerae non-O1 isolates from a US gulf coast cholera outbreak. PLoS One. 2014;9:e86264.PubMedPubMedCentral
8.
Zurück zum Zitat Waldor MK, Mekalanos JJ. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science. 1996;272:1910–4.PubMed Waldor MK, Mekalanos JJ. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science. 1996;272:1910–4.PubMed
9.
Zurück zum Zitat Karaolis DK, Johnson JA, Bailey CC, Boedeker EC, Kaper JB, Reeves PR. A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains. Proc Natl Acad Sci U S A. 1998;95:3134–9.PubMedPubMedCentral Karaolis DK, Johnson JA, Bailey CC, Boedeker EC, Kaper JB, Reeves PR. A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains. Proc Natl Acad Sci U S A. 1998;95:3134–9.PubMedPubMedCentral
10.
Zurück zum Zitat Ajayi A, Smith SI. Recurrent cholera epidemics in Africa: which way forward? A literature review. Infection. 2019;47:341–9.PubMed Ajayi A, Smith SI. Recurrent cholera epidemics in Africa: which way forward? A literature review. Infection. 2019;47:341–9.PubMed
11.
Zurück zum Zitat Pulungsih SP, Punjabi NH, Rafli K, Rifajati A, Kumala S, Simanjuntak CH, Yuwono, Lesmana M, Subekti D, Sutoto, Fontaine O. Standard WHO-ORS versus reduced-osmolarity ORS in the management of cholera patients. J Health Popul Nutr. 2006;24:107–12.PubMed Pulungsih SP, Punjabi NH, Rafli K, Rifajati A, Kumala S, Simanjuntak CH, Yuwono, Lesmana M, Subekti D, Sutoto, Fontaine O. Standard WHO-ORS versus reduced-osmolarity ORS in the management of cholera patients. J Health Popul Nutr. 2006;24:107–12.PubMed
13.
Zurück zum Zitat Pietroni MAC. Case management of cholera. Vaccine. 2020;38(1):A105–A9.PubMed Pietroni MAC. Case management of cholera. Vaccine. 2020;38(1):A105–A9.PubMed
14.
Zurück zum Zitat Chac D, Dunmire CN, Singh J, Weil AA. Update on environmental and host factors impacting the risk of Vibrio cholerae infection. ACS Infect Dis. 2021;7:1010–9.PubMed Chac D, Dunmire CN, Singh J, Weil AA. Update on environmental and host factors impacting the risk of Vibrio cholerae infection. ACS Infect Dis. 2021;7:1010–9.PubMed
15.
Zurück zum Zitat Khan AI, Islam MT, Khan ZH, Tanvir NA, Amin MA, Khan II, Bhuiyan A, Hasan A, Islam MS, Bari TIA, Rahman A, Islam MN, Qadri F. Implementation and delivery of oral cholera vaccination campaigns in humanitarian crisis settings among Rohingya Myanmar nationals in Cox’s bazar, Bangladesh. Vaccines (Basel). 2023;11:843.PubMed Khan AI, Islam MT, Khan ZH, Tanvir NA, Amin MA, Khan II, Bhuiyan A, Hasan A, Islam MS, Bari TIA, Rahman A, Islam MN, Qadri F. Implementation and delivery of oral cholera vaccination campaigns in humanitarian crisis settings among Rohingya Myanmar nationals in Cox’s bazar, Bangladesh. Vaccines (Basel). 2023;11:843.PubMed
16.
Zurück zum Zitat Ali M, Nelson AR, Lopez AL, Sack DA. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis. 2015;9:e3832.PubMedPubMedCentral Ali M, Nelson AR, Lopez AL, Sack DA. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis. 2015;9:e3832.PubMedPubMedCentral
17.
Zurück zum Zitat Rouard C, Njamkepo E, Quilici ML, Weill FX. Contribution of microbial genomics to cholera epidemiology. C R Biol. 2022;345:37–56.PubMed Rouard C, Njamkepo E, Quilici ML, Weill FX. Contribution of microbial genomics to cholera epidemiology. C R Biol. 2022;345:37–56.PubMed
19.
Zurück zum Zitat Huhulescu S, Leitner E, Feierl G, Allerberger F. Laboratory-acquired Vibrio cholerae O1 infection in Austria, 2008. Clin Microbiol Infect. 2010;16:1303–4.PubMed Huhulescu S, Leitner E, Feierl G, Allerberger F. Laboratory-acquired Vibrio cholerae O1 infection in Austria, 2008. Clin Microbiol Infect. 2010;16:1303–4.PubMed
20.
Zurück zum Zitat Vezzulli L, Baker-Austin C, Kirschner A, Pruzzo C, Martinez-Urtaza J. Global emergence of environmental non-O1/O139 Vibrio cholerae infections linked with climate change: a neglected research field? Environ Microbiol. 2020;22:4342–55.PubMed Vezzulli L, Baker-Austin C, Kirschner A, Pruzzo C, Martinez-Urtaza J. Global emergence of environmental non-O1/O139 Vibrio cholerae infections linked with climate change: a neglected research field? Environ Microbiol. 2020;22:4342–55.PubMed
21.
Zurück zum Zitat Schwartz K, Hammerl JA, Göllner C, Strauch E. Environmental and clinical strains of Vibrio cholerae non-O1, non-O139 from Germany possess similar virulence gene profiles. Front Microbiol. 2019;10:733.PubMedPubMedCentral Schwartz K, Hammerl JA, Göllner C, Strauch E. Environmental and clinical strains of Vibrio cholerae non-O1, non-O139 from Germany possess similar virulence gene profiles. Front Microbiol. 2019;10:733.PubMedPubMedCentral
22.
Zurück zum Zitat Engel MF, Muijsken MA, Mooi-Kokenberg E, Kuijper EJ, van Westerloo DJ. Vibrio cholerae non-O1 bacteraemia: description of three cases in the Netherlands and a literature review. Euro Surveill. 2016;21:15. Engel MF, Muijsken MA, Mooi-Kokenberg E, Kuijper EJ, van Westerloo DJ. Vibrio cholerae non-O1 bacteraemia: description of three cases in the Netherlands and a literature review. Euro Surveill. 2016;21:15.
23.
Zurück zum Zitat Chen YT, Tang HJ, Chao CM, Lai CC. Clinical manifestations of non-O1 Vibrio cholerae infections. PLoS ONE. 2015;10:e116904.PubMedPubMedCentral Chen YT, Tang HJ, Chao CM, Lai CC. Clinical manifestations of non-O1 Vibrio cholerae infections. PLoS ONE. 2015;10:e116904.PubMedPubMedCentral
24.
Zurück zum Zitat Hirk S, Huhulescu S, Allerberger F, Lepuschitz S, Rehak S, Weil S, Gschwandtner E, Hermann M, Neuhold S, Zoufaly A, Indra A. Necrotizing fasciitis due to Vibrio cholerae non-O1/non-O139 after exposure to Austrian bathing sites. Wien Klin Wochenschr. 2016;128:141–5.PubMedPubMedCentral Hirk S, Huhulescu S, Allerberger F, Lepuschitz S, Rehak S, Weil S, Gschwandtner E, Hermann M, Neuhold S, Zoufaly A, Indra A. Necrotizing fasciitis due to Vibrio cholerae non-O1/non-O139 after exposure to Austrian bathing sites. Wien Klin Wochenschr. 2016;128:141–5.PubMedPubMedCentral
25.
Zurück zum Zitat Hao Y, Wang Y, Bi Z, Sun B, Jin Y, Bai Y, Chen B, Shao C, Sun X, Lu Z. A case of non-O1/non-O139 Vibrio cholerae septicemia and meningitis in a neonate. Int J Infect Dis. 2015;35:117–9.PubMed Hao Y, Wang Y, Bi Z, Sun B, Jin Y, Bai Y, Chen B, Shao C, Sun X, Lu Z. A case of non-O1/non-O139 Vibrio cholerae septicemia and meningitis in a neonate. Int J Infect Dis. 2015;35:117–9.PubMed
26.
Zurück zum Zitat Chen WD, Lai LJ, Hsu WH, Huang TY. Vibrio cholerae non-O1—the first reported case of keratitis in a healthy patient. BMC Infect Dis. 2019;19:916.PubMedPubMedCentral Chen WD, Lai LJ, Hsu WH, Huang TY. Vibrio cholerae non-O1—the first reported case of keratitis in a healthy patient. BMC Infect Dis. 2019;19:916.PubMedPubMedCentral
27.
Zurück zum Zitat Wilson R, Lieb S, Roberts A, Stryker S, Janowski H, Gunn R, Davis B, Riddle CF, Barrett T, Morris JG Jr., Blake PA. Non‑O group 1 Vibrio cholerae gastroenteritis associated with eating raw oysters. Am J Epidemiol. 1981;114:293–8.PubMed Wilson R, Lieb S, Roberts A, Stryker S, Janowski H, Gunn R, Davis B, Riddle CF, Barrett T, Morris JG Jr., Blake PA. Non‑O group 1 Vibrio cholerae gastroenteritis associated with eating raw oysters. Am J Epidemiol. 1981;114:293–8.PubMed
28.
Zurück zum Zitat Huhulescu S, Indra A, Feierl G, Stoeger A, Ruppitsch W, Sarkar B, Allerberger F. Occurrence of Vibrio cholerae serogroups other than O1 and O139 in Austria. Wien Klin Wochenschr. 2007;119:235–41.PubMed Huhulescu S, Indra A, Feierl G, Stoeger A, Ruppitsch W, Sarkar B, Allerberger F. Occurrence of Vibrio cholerae serogroups other than O1 and O139 in Austria. Wien Klin Wochenschr. 2007;119:235–41.PubMed
29.
Zurück zum Zitat Van Bonn SM, Schraven SP, Schuldt T, Heimesaat MM, Mlynski R, Warnke PC. Chronic otitis media following infection by non-O1/non-O139 Vibrio cholerae: a case report and review of the literature. Eur J Microbiol Immunol (Bp). 2020;10:186–91.PubMed Van Bonn SM, Schraven SP, Schuldt T, Heimesaat MM, Mlynski R, Warnke PC. Chronic otitis media following infection by non-O1/non-O139 Vibrio cholerae: a case report and review of the literature. Eur J Microbiol Immunol (Bp). 2020;10:186–91.PubMed
30.
Zurück zum Zitat Maraki S, Christidou A, Anastasaki M, Scoulica E. Non-O1, non-O139 Vibrio cholerae bacteremic skin and soft tissue infections. Infect Dis (Lond). 2016;48:171–6.PubMed Maraki S, Christidou A, Anastasaki M, Scoulica E. Non-O1, non-O139 Vibrio cholerae bacteremic skin and soft tissue infections. Infect Dis (Lond). 2016;48:171–6.PubMed
31.
Zurück zum Zitat Deshayes S, Daurel C, Cattoir V, Parienti JJ, Quilici ML, de La Blanchardière A. Non-O1, non-O139 Vibrio cholerae bacteraemia: case report and literature review. SpringerPlus. 2015;4:575.PubMedPubMedCentral Deshayes S, Daurel C, Cattoir V, Parienti JJ, Quilici ML, de La Blanchardière A. Non-O1, non-O139 Vibrio cholerae bacteraemia: case report and literature review. SpringerPlus. 2015;4:575.PubMedPubMedCentral
32.
Zurück zum Zitat Schirmeister F, Dieckmann R, Bechlars S, Bier N, Faruque SM, Strauch E. Genetic and phenotypic analysis of Vibrio cholerae non-O1, non-O139 isolated from German and Austrian patients. Eur J Clin Microbiol Infect Dis. 2014;33:767–78.PubMed Schirmeister F, Dieckmann R, Bechlars S, Bier N, Faruque SM, Strauch E. Genetic and phenotypic analysis of Vibrio cholerae non-O1, non-O139 isolated from German and Austrian patients. Eur J Clin Microbiol Infect Dis. 2014;33:767–78.PubMed
33.
Zurück zum Zitat Baker-Austin C, Oliver JD, Alam M, Ali A, Waldor MK, Qadri F, Martinez-Urtaza J. Vibrio spp. infections. Nat Rev Dis Primers. 2018;4:8.PubMed Baker-Austin C, Oliver JD, Alam M, Ali A, Waldor MK, Qadri F, Martinez-Urtaza J. Vibrio spp. infections. Nat Rev Dis Primers. 2018;4:8.PubMed
34.
Zurück zum Zitat Lepuschitz S, Baron S, Larvor E, Granier SA, Pretzer C, Mach RL, Farnleitner AH, Ruppitsch W, Pleininger S, Indra A, Kirschner AKT. Phenotypic and genotypic antimicrobial resistance traits of Vibrio cholerae non-O1/non-O139 isolated from a large Austrian lake frequently associated with cases of human infection. Front Microbiol. 2019;10:2600.PubMedPubMedCentral Lepuschitz S, Baron S, Larvor E, Granier SA, Pretzer C, Mach RL, Farnleitner AH, Ruppitsch W, Pleininger S, Indra A, Kirschner AKT. Phenotypic and genotypic antimicrobial resistance traits of Vibrio cholerae non-O1/non-O139 isolated from a large Austrian lake frequently associated with cases of human infection. Front Microbiol. 2019;10:2600.PubMedPubMedCentral
35.
Zurück zum Zitat Baron S, Larvor E, Chevalier S, Jouy E, Kempf I, Granier SA, Lesne J. Antimicrobial susceptibility among urban wastewater and wild shellfish isolates of non-O1/non-O139 Vibrio cholerae from La Rance Estuary (Brittany, France). Front Microbiol. 2017;8:1637.PubMedPubMedCentral Baron S, Larvor E, Chevalier S, Jouy E, Kempf I, Granier SA, Lesne J. Antimicrobial susceptibility among urban wastewater and wild shellfish isolates of non-O1/non-O139 Vibrio cholerae from La Rance Estuary (Brittany, France). Front Microbiol. 2017;8:1637.PubMedPubMedCentral
36.
Zurück zum Zitat Bier N, Schwartz K, Guerra B, Strauch E. Survey on antimicrobial resistance patterns in Vibrio vulnificus and Vibrio cholerae non-O1/non-O139 in Germany reveals carbapenemase-producing Vibrio cholerae in coastal waters. Front Microbiol. 2015;6:1179.PubMedPubMedCentral Bier N, Schwartz K, Guerra B, Strauch E. Survey on antimicrobial resistance patterns in Vibrio vulnificus and Vibrio cholerae non-O1/non-O139 in Germany reveals carbapenemase-producing Vibrio cholerae in coastal waters. Front Microbiol. 2015;6:1179.PubMedPubMedCentral
37.
Zurück zum Zitat Ceccarelli D, Chen A, Hasan NA, Rashed SM, Huq A, Colwell RR. Non-O1/non-O139 Vibrio cholerae carrying multiple virulence factors and V. cholerae O1 in the Chesapeake Bay, Maryland. Appl Environ Microbiol. 2015;81:1909–18.PubMedPubMedCentral Ceccarelli D, Chen A, Hasan NA, Rashed SM, Huq A, Colwell RR. Non-O1/non-O139 Vibrio cholerae carrying multiple virulence factors and V. cholerae O1 in the Chesapeake Bay, Maryland. Appl Environ Microbiol. 2015;81:1909–18.PubMedPubMedCentral
38.
Zurück zum Zitat Wu X, Vaziri AZ, Omidi N, Kaviar VH, Maleki A, Khadivar P, Kouhsari E. Antimicrobial resistance among clinical Vibrio cholerae non-O1/non-O139 isolates: systematic review and meta-analysis: systematic review and meta-analysis. Pathog Glob Health. 2023;117:235–44.PubMed Wu X, Vaziri AZ, Omidi N, Kaviar VH, Maleki A, Khadivar P, Kouhsari E. Antimicrobial resistance among clinical Vibrio cholerae non-O1/non-O139 isolates: systematic review and meta-analysis: systematic review and meta-analysis. Pathog Glob Health. 2023;117:235–44.PubMed
39.
Zurück zum Zitat Igere BE, Okoh AI, Nwodo UU. Antibiotic susceptibility testing (AST) reports: a basis for environmental/epidemiological surveillance and infection control amongst environmental Vibrio cholerae. Int J Environ Res Public Health. 2020;17:5685.PubMedPubMedCentral Igere BE, Okoh AI, Nwodo UU. Antibiotic susceptibility testing (AST) reports: a basis for environmental/epidemiological surveillance and infection control amongst environmental Vibrio cholerae. Int J Environ Res Public Health. 2020;17:5685.PubMedPubMedCentral
40.
Zurück zum Zitat Takemura AF, Chien DM, Polz MF. Associations and dynamics of Vibrionaceae in the environment, from the genus to the population level. Front Microbiol. 2014;5:38.PubMedPubMedCentral Takemura AF, Chien DM, Polz MF. Associations and dynamics of Vibrionaceae in the environment, from the genus to the population level. Front Microbiol. 2014;5:38.PubMedPubMedCentral
41.
Zurück zum Zitat Kirschner AK, Schlesinger J, Farnleitner AH, Hornek R, Süss B, Golda B, Herzig A, Reitner B. Rapid growth of planktonic Vibrio cholerae non-O1/non-O139 strains in a large alkaline lake in Austria: dependence on temperature and dissolved organic carbon quality. Appl Environ Microbiol. 2008;74:2004–15.PubMedPubMedCentral Kirschner AK, Schlesinger J, Farnleitner AH, Hornek R, Süss B, Golda B, Herzig A, Reitner B. Rapid growth of planktonic Vibrio cholerae non-O1/non-O139 strains in a large alkaline lake in Austria: dependence on temperature and dissolved organic carbon quality. Appl Environ Microbiol. 2008;74:2004–15.PubMedPubMedCentral
42.
Zurück zum Zitat Schauer S, Jakwerth S, Bliem R, Baudart J, Lebaron P, Huhulescu S, Kundi M, Herzig A, Farnleitner AH, Sommer R, Kirschner A. Dynamics of Vibrio cholerae abundance in Austrian saline lakes, assessed with quantitative solid-phase cytometry. Environ Microbiol. 2015;17:4366–78.PubMedPubMedCentral Schauer S, Jakwerth S, Bliem R, Baudart J, Lebaron P, Huhulescu S, Kundi M, Herzig A, Farnleitner AH, Sommer R, Kirschner A. Dynamics of Vibrio cholerae abundance in Austrian saline lakes, assessed with quantitative solid-phase cytometry. Environ Microbiol. 2015;17:4366–78.PubMedPubMedCentral
43.
Zurück zum Zitat Huq A, Small EB, West PA, Huq MI, Rahman R, Colwell RR. Ecological relationships between Vibrio cholerae and planktonic crustacean copepods. Appl Environ Microbiol. 1983;45:275–83.PubMedPubMedCentral Huq A, Small EB, West PA, Huq MI, Rahman R, Colwell RR. Ecological relationships between Vibrio cholerae and planktonic crustacean copepods. Appl Environ Microbiol. 1983;45:275–83.PubMedPubMedCentral
44.
Zurück zum Zitat Kirschner AK, Schauer S, Steinberger B, Wilhartitz I, Grim CJ, Huq A, Colwell RR, Herzig A, Sommer R. Interaction of Vibrio cholerae non-O1/non-O139 with copepods, cladocerans and competing bacteria in the large alkaline lake Neusiedler See, Austria. Microb Ecol. 2011;61:496–506.PubMed Kirschner AK, Schauer S, Steinberger B, Wilhartitz I, Grim CJ, Huq A, Colwell RR, Herzig A, Sommer R. Interaction of Vibrio cholerae non-O1/non-O139 with copepods, cladocerans and competing bacteria in the large alkaline lake Neusiedler See, Austria. Microb Ecol. 2011;61:496–506.PubMed
45.
Zurück zum Zitat Metzger LC, Blokesch M. Regulation of competence-mediated horizontal gene transfer in the natural habitat of Vibrio cholerae. Curr Opin Microbiol. 2016;30:1–7.PubMed Metzger LC, Blokesch M. Regulation of competence-mediated horizontal gene transfer in the natural habitat of Vibrio cholerae. Curr Opin Microbiol. 2016;30:1–7.PubMed
46.
Zurück zum Zitat Halpern M, Broza YB, Mittler S, Arakawa E, Broza M. Chironomid egg masses as a natural reservoir of Vibrio cholerae non-O1 and non-O139 in freshwater habitats. Microb Ecol. 2004;47:341–9.PubMed Halpern M, Broza YB, Mittler S, Arakawa E, Broza M. Chironomid egg masses as a natural reservoir of Vibrio cholerae non-O1 and non-O139 in freshwater habitats. Microb Ecol. 2004;47:341–9.PubMed
48.
Zurück zum Zitat Laviad-Shitrit S, Izhaki I, Halpern M. Accumulating evidence suggests that some waterbird species are potential vectors of Vibrio cholerae. PLoS Pathog. 2019;15:e1007814.PubMedPubMedCentral Laviad-Shitrit S, Izhaki I, Halpern M. Accumulating evidence suggests that some waterbird species are potential vectors of Vibrio cholerae. PLoS Pathog. 2019;15:e1007814.PubMedPubMedCentral
49.
Zurück zum Zitat Espinoza-Vergara G, Noorian P, Silva-Valenzuela CA, Raymond BBA, Allen C, Hoque MM, Sun S, Johnson MS, Pernice M, Kjelleberg S, Djordjevic SP, Labbate M, Camilli A, McDougald D. Vibrio cholerae residing in food vacuoles expelled by protozoa are more infectious in vivo. Nat Microbiol. 2019;4:2466–74.PubMedPubMedCentral Espinoza-Vergara G, Noorian P, Silva-Valenzuela CA, Raymond BBA, Allen C, Hoque MM, Sun S, Johnson MS, Pernice M, Kjelleberg S, Djordjevic SP, Labbate M, Camilli A, McDougald D. Vibrio cholerae residing in food vacuoles expelled by protozoa are more infectious in vivo. Nat Microbiol. 2019;4:2466–74.PubMedPubMedCentral
50.
Zurück zum Zitat Debnath A, Mizuno T, Miyoshi SI. Comparative proteomic analysis to characterize temperature-induced viable but non-culturable and resuscitation states in Vibrio cholerae. Microbiology. 2019;165:737–46.PubMed Debnath A, Mizuno T, Miyoshi SI. Comparative proteomic analysis to characterize temperature-induced viable but non-culturable and resuscitation states in Vibrio cholerae. Microbiology. 2019;165:737–46.PubMed
51.
Zurück zum Zitat Ravel J, Knight IT, Monahan CE, Hill RT, Colwell RR. Temperature-induced recovery of Vibrio cholerae from the viable but nonculturable state: growth or resuscitation? Microbiology. 1995;141(2):377–83.PubMed Ravel J, Knight IT, Monahan CE, Hill RT, Colwell RR. Temperature-induced recovery of Vibrio cholerae from the viable but nonculturable state: growth or resuscitation? Microbiology. 1995;141(2):377–83.PubMed
52.
Zurück zum Zitat IPCC. Synthesis report of the IPCC sixth assessment report (AR6)—summary for policy makers. 2023. p. 36. IPCC. Synthesis report of the IPCC sixth assessment report (AR6)—summary for policy makers. 2023. p. 36.
53.
Zurück zum Zitat Vezzulli L, Grande C, Reid PC, Hélaouët P, Edwards M, Höfle MG, Brettar I, Colwell RR, Pruzzo C. Climate influence on Vibrio and associated human diseases during the past half-century in the coastal North Atlantic. Proc Natl Acad Sci U S A. 2016;113:E5062–71.PubMedPubMedCentral Vezzulli L, Grande C, Reid PC, Hélaouët P, Edwards M, Höfle MG, Brettar I, Colwell RR, Pruzzo C. Climate influence on Vibrio and associated human diseases during the past half-century in the coastal North Atlantic. Proc Natl Acad Sci U S A. 2016;113:E5062–71.PubMedPubMedCentral
54.
Zurück zum Zitat Dokulil MT, de Eyto E, Maberly SC, May L, Weyhenmeyer GA, Woolway RI. Increasing maximum lake surface temperature under climate change. Clim Change. 2021;165:56. Dokulil MT, de Eyto E, Maberly SC, May L, Weyhenmeyer GA, Woolway RI. Increasing maximum lake surface temperature under climate change. Clim Change. 2021;165:56.
55.
Zurück zum Zitat Escobar LE, Ryan SJ, Stewart-Ibarra AM, Finkelstein JL, King CA, Qiao H, Polhemus ME. A global map of suitability for coastal Vibrio cholerae under current and future climate conditions. Acta Trop. 2015;149:202–11.PubMed Escobar LE, Ryan SJ, Stewart-Ibarra AM, Finkelstein JL, King CA, Qiao H, Polhemus ME. A global map of suitability for coastal Vibrio cholerae under current and future climate conditions. Acta Trop. 2015;149:202–11.PubMed
56.
Zurück zum Zitat Vezzulli L, Brettar I, Pezzati E, Reid PC, Colwell RR, Höfle MG, Pruzzo C. Long-term effects of ocean warming on the prokaryotic community: evidence from the vibrios. ISME J. 2012;6:21–30.PubMed Vezzulli L, Brettar I, Pezzati E, Reid PC, Colwell RR, Höfle MG, Pruzzo C. Long-term effects of ocean warming on the prokaryotic community: evidence from the vibrios. ISME J. 2012;6:21–30.PubMed
57.
Zurück zum Zitat Vezzulli L, Colwell RR, Pruzzo C. Ocean warming and spread of pathogenic vibrios in the aquatic environment. Microb Ecol. 2013;65:817–25.PubMed Vezzulli L, Colwell RR, Pruzzo C. Ocean warming and spread of pathogenic vibrios in the aquatic environment. Microb Ecol. 2013;65:817–25.PubMed
58.
Zurück zum Zitat Baker-Austin C, Trinanes J, Gonzalez-Escalona N, Martinez-Urtaza J. Non-cholera Vibrios: the microbial barometer of climate change. Trends Microbiol. 2017;25:76–84.PubMed Baker-Austin C, Trinanes J, Gonzalez-Escalona N, Martinez-Urtaza J. Non-cholera Vibrios: the microbial barometer of climate change. Trends Microbiol. 2017;25:76–84.PubMed
59.
Zurück zum Zitat Brehm TT, Berneking L, Sena Martins M, Dupke S, Jacob D, Drechsel O, Bohnert J, Becker K, Kramer A, Christner M, Aepfelbacher M, Schmiedel S, Rohde H. Heatwave-associated Vibrio infections in Germany, 2018 and 2019. Euro Surveill. 2021;26:2002041.PubMedPubMedCentral Brehm TT, Berneking L, Sena Martins M, Dupke S, Jacob D, Drechsel O, Bohnert J, Becker K, Kramer A, Christner M, Aepfelbacher M, Schmiedel S, Rohde H. Heatwave-associated Vibrio infections in Germany, 2018 and 2019. Euro Surveill. 2021;26:2002041.PubMedPubMedCentral
60.
Zurück zum Zitat Baker-Austin C, Trinanes JA, Salmenlinna S, Löfdahl M, Siitonen A, Taylor NG, Martinez-Urtaza J. Heat wave-associated Vibriosis, Sweden and Finland, 2014. Emerg Infect Dis. 2016;22:1216–20.PubMedPubMedCentral Baker-Austin C, Trinanes JA, Salmenlinna S, Löfdahl M, Siitonen A, Taylor NG, Martinez-Urtaza J. Heat wave-associated Vibriosis, Sweden and Finland, 2014. Emerg Infect Dis. 2016;22:1216–20.PubMedPubMedCentral
61.
Zurück zum Zitat Newton A, Kendall M, Vugia DJ, Henao OL, Mahon BE. Increasing rates of vibriosis in the United States, 1996–2010: review of surveillance data from 2 systems. Clin Infect Dis. 2012;54(5):S391–5.PubMed Newton A, Kendall M, Vugia DJ, Henao OL, Mahon BE. Increasing rates of vibriosis in the United States, 1996–2010: review of surveillance data from 2 systems. Clin Infect Dis. 2012;54(5):S391–5.PubMed
62.
Zurück zum Zitat Dieckmann R, Strauch E, Alter T. Rapid identification and characterization of Vibrio species using whole-cell MALDI-TOF mass spectrometry. J Appl Microbiol. 2010;109:199–211.PubMed Dieckmann R, Strauch E, Alter T. Rapid identification and characterization of Vibrio species using whole-cell MALDI-TOF mass spectrometry. J Appl Microbiol. 2010;109:199–211.PubMed
63.
Zurück zum Zitat Baron S, Chevalier S, Lesne J. Vibrio cholerae in the environment: a simple method for reliable identification of the species. J Health Popul Nutr. 2007;25:312–8.PubMedPubMedCentral Baron S, Chevalier S, Lesne J. Vibrio cholerae in the environment: a simple method for reliable identification of the species. J Health Popul Nutr. 2007;25:312–8.PubMedPubMedCentral
64.
Zurück zum Zitat Kirschner AKT, Pleininger S, Jakwerth S, Rehak S, Farnleitner AH, Huhulescu S, Indra A. Application of three different methods to determine the prevalence, the abundance and the environmental drivers of culturable Vibrio cholerae in fresh and brackish bathing waters. J Appl Microbiol. 2018;125:1186–98.PubMedPubMedCentral Kirschner AKT, Pleininger S, Jakwerth S, Rehak S, Farnleitner AH, Huhulescu S, Indra A. Application of three different methods to determine the prevalence, the abundance and the environmental drivers of culturable Vibrio cholerae in fresh and brackish bathing waters. J Appl Microbiol. 2018;125:1186–98.PubMedPubMedCentral
65.
Zurück zum Zitat Greig DR, Schaefer U, Octavia S, Hunter E, Chattaway MA, Dallman TJ, Jenkins C. Evaluation of whole-genome sequencing for identification and typing of Vibrio cholerae. J Clin Microbiol. 2018;56:e831–18.PubMedPubMedCentral Greig DR, Schaefer U, Octavia S, Hunter E, Chattaway MA, Dallman TJ, Jenkins C. Evaluation of whole-genome sequencing for identification and typing of Vibrio cholerae. J Clin Microbiol. 2018;56:e831–18.PubMedPubMedCentral
66.
Zurück zum Zitat Davis BR, Fanning GR, Madden JM, Steigerwalt AG, Bradford HB Jr., Smith HL Jr., Brenner DJ. Characterization of biochemically atypical Vibrio cholerae strains and designation of a new pathogenic species, Vibrio mimicus. J Clin Microbiol. 1981;14:631–9.PubMedPubMedCentral Davis BR, Fanning GR, Madden JM, Steigerwalt AG, Bradford HB Jr., Smith HL Jr., Brenner DJ. Characterization of biochemically atypical Vibrio cholerae strains and designation of a new pathogenic species, Vibrio mimicus. J Clin Microbiol. 1981;14:631–9.PubMedPubMedCentral
67.
Zurück zum Zitat Kirchberger PC, Turnsek M, Hunt DE, Haley BJ, Colwell RR, Polz MF, Tarr CL, Boucher Y. Vibrio metoecus sp. nov., a close relative of Vibrio cholerae isolated from coastal brackish ponds and clinical specimens. Int J Syst Evol Microbiol. 2014;64:3208–14.PubMed Kirchberger PC, Turnsek M, Hunt DE, Haley BJ, Colwell RR, Polz MF, Tarr CL, Boucher Y. Vibrio metoecus sp. nov., a close relative of Vibrio cholerae isolated from coastal brackish ponds and clinical specimens. Int J Syst Evol Microbiol. 2014;64:3208–14.PubMed
68.
Zurück zum Zitat Islam MT, Nasreen T, Kirchberger PC, Liang KYH, Orata FD, Johura FT, Hussain NAS, Im MS, Tarr CL, Alam M, Boucher YF. Population analysis of Vibrio cholerae in aquatic reservoirs reveals a novel sister species (Vibrio paracholerae sp. nov.) with a history of association with humans. Appl Environ Microbiol. 2021;87:e42221.PubMed Islam MT, Nasreen T, Kirchberger PC, Liang KYH, Orata FD, Johura FT, Hussain NAS, Im MS, Tarr CL, Alam M, Boucher YF. Population analysis of Vibrio cholerae in aquatic reservoirs reveals a novel sister species (Vibrio paracholerae sp. nov.) with a history of association with humans. Appl Environ Microbiol. 2021;87:e42221.PubMed
69.
Zurück zum Zitat Kondo S, Iguchi T, Hisatsune K. A comparative study of the sugar composition of lipopolysaccharides isolated from Vibrio cholerae, ‘Vibrio albensis’ and Vibrio metschnikovii. J Gen Microbiol. 1988;134:1699–705.PubMed Kondo S, Iguchi T, Hisatsune K. A comparative study of the sugar composition of lipopolysaccharides isolated from Vibrio cholerae, ‘Vibrio albensis’ and Vibrio metschnikovii. J Gen Microbiol. 1988;134:1699–705.PubMed
70.
Zurück zum Zitat Pretzer C, Druzhinina IS, Amaro C, Benediktsdóttir E, Hedenström I, Hervio-Heath D, Huhulescu S, Schets FM, Farnleitner AH, Kirschner AKT. High genetic diversity of Vibrio cholerae in the European lake Neusiedler See is associated with intensive recombination in the reed habitat and the long-distance transfer of strains. Environ Microbiol. 2017;19:328–44.PubMedPubMedCentral Pretzer C, Druzhinina IS, Amaro C, Benediktsdóttir E, Hedenström I, Hervio-Heath D, Huhulescu S, Schets FM, Farnleitner AH, Kirschner AKT. High genetic diversity of Vibrio cholerae in the European lake Neusiedler See is associated with intensive recombination in the reed habitat and the long-distance transfer of strains. Environ Microbiol. 2017;19:328–44.PubMedPubMedCentral
71.
Zurück zum Zitat Keymer DP, Lam LH, Boehm AB. Biogeographic patterns in genomic diversity among a large collection of Vibrio cholerae isolates. Appl Environ Microbiol. 2009;75:1658–66.PubMedPubMedCentral Keymer DP, Lam LH, Boehm AB. Biogeographic patterns in genomic diversity among a large collection of Vibrio cholerae isolates. Appl Environ Microbiol. 2009;75:1658–66.PubMedPubMedCentral
72.
Zurück zum Zitat Keymer DP, Miller MC, Schoolnik GK, Boehm AB. Genomic and phenotypic diversity of coastal Vibrio cholerae strains is linked to environmental factors. Appl Environ Microbiol. 2007;73:3705–14.PubMedPubMedCentral Keymer DP, Miller MC, Schoolnik GK, Boehm AB. Genomic and phenotypic diversity of coastal Vibrio cholerae strains is linked to environmental factors. Appl Environ Microbiol. 2007;73:3705–14.PubMedPubMedCentral
73.
Zurück zum Zitat Arya SC. Utility of rapid monoclonal antibody-based coagglutination test for direct detection of Vibrio cholerae O1 and/or O139 in stool samples. J Clin Microbiol. 1995;33:509–10.PubMedPubMedCentral Arya SC. Utility of rapid monoclonal antibody-based coagglutination test for direct detection of Vibrio cholerae O1 and/or O139 in stool samples. J Clin Microbiol. 1995;33:509–10.PubMedPubMedCentral
74.
Zurück zum Zitat Cameron DN, Khambaty FM, Wachsmuth IK, Tauxe RV, Barrett TJ. Molecular characterization of Vibrio cholerae O1 strains by pulsed-field gel electrophoresis. J Clin Microbiol. 1994;32:1685–90.PubMedPubMedCentral Cameron DN, Khambaty FM, Wachsmuth IK, Tauxe RV, Barrett TJ. Molecular characterization of Vibrio cholerae O1 strains by pulsed-field gel electrophoresis. J Clin Microbiol. 1994;32:1685–90.PubMedPubMedCentral
75.
Zurück zum Zitat Popovic T, Bopp C, Olsvik O, Wachsmuth K. Epidemiologic application of a standardized ribotype scheme for Vibrio cholerae O1. J Clin Microbiol. 1993;31:2474–82.PubMedPubMedCentral Popovic T, Bopp C, Olsvik O, Wachsmuth K. Epidemiologic application of a standardized ribotype scheme for Vibrio cholerae O1. J Clin Microbiol. 1993;31:2474–82.PubMedPubMedCentral
76.
Zurück zum Zitat Jiang SC, Louis V, Choopun N, Sharma A, Huq A, Colwell RR. Genetic diversity of Vibrio cholerae in Chesapeake Bay determined by amplified fragment length polymorphism fingerprinting. Appl Environ Microbiol. 2000;66:140–7.PubMedPubMedCentral Jiang SC, Louis V, Choopun N, Sharma A, Huq A, Colwell RR. Genetic diversity of Vibrio cholerae in Chesapeake Bay determined by amplified fragment length polymorphism fingerprinting. Appl Environ Microbiol. 2000;66:140–7.PubMedPubMedCentral
77.
Zurück zum Zitat Rivera IG, Chowdhury MA, Huq A, Jacobs D, Martins MT, Colwell RR. Enterobacterial repetitive intergenic consensus sequences and the PCR to generate fingerprints of genomic DNAs from Vibrio cholerae O1, O139, and non-O1 strains. Appl Environ Microbiol. 1995;61:2898–904.PubMedPubMedCentral Rivera IG, Chowdhury MA, Huq A, Jacobs D, Martins MT, Colwell RR. Enterobacterial repetitive intergenic consensus sequences and the PCR to generate fingerprints of genomic DNAs from Vibrio cholerae O1, O139, and non-O1 strains. Appl Environ Microbiol. 1995;61:2898–904.PubMedPubMedCentral
78.
Zurück zum Zitat Octavia S, Salim A, Kurniawan J, Lam C, Leung Q, Ahsan S, Reeves PR, Nair GB, Lan R. Population structure and evolution of non-O1/non-O139 Vibrio cholerae by multilocus sequence typing. PLoS One. 2013;8:e65342.PubMedPubMedCentral Octavia S, Salim A, Kurniawan J, Lam C, Leung Q, Ahsan S, Reeves PR, Nair GB, Lan R. Population structure and evolution of non-O1/non-O139 Vibrio cholerae by multilocus sequence typing. PLoS One. 2013;8:e65342.PubMedPubMedCentral
79.
Zurück zum Zitat Liang KYH, Orata FD, Islam MT, Nasreen T, Alam M, Tarr CL, Boucher YF. A Vibrio cholerae core genome multilocus sequence typing scheme to facilitate the epidemiological study of cholera. J Bacteriol. 2020;202:e86–20.PubMedPubMedCentral Liang KYH, Orata FD, Islam MT, Nasreen T, Alam M, Tarr CL, Boucher YF. A Vibrio cholerae core genome multilocus sequence typing scheme to facilitate the epidemiological study of cholera. J Bacteriol. 2020;202:e86–20.PubMedPubMedCentral
80.
Zurück zum Zitat ISO. Microbiology of food and animal feeding stuffs—horizontal method for the detection of potentially enteropathogenic Vibrio spp. Geneva, Switzerland: International Organisation of Standardisation; 2007. pp. 1–19. ISO. Microbiology of food and animal feeding stuffs—horizontal method for the detection of potentially enteropathogenic Vibrio spp. Geneva, Switzerland: International Organisation of Standardisation; 2007. pp. 1–19.
81.
Zurück zum Zitat Rehm C, Lippert K, Indra A, Kolarević S, Kračun-Kolarević M, Leopold M, Steinbacher S, Schachner I, Campostrini L, Risslegger A, Farnleitner AH, Kolm C, Kirschner AKT. First report on the occurrence of Vibrio cholerae nonO1/nonO139 in natural and artificial lakes and ponds in Serbia: evidence for a long-distance transfer of strains and the presence of Vibrio paracholerae. Environ Microbiol Rep. 2023;15:142–52.PubMedPubMedCentral Rehm C, Lippert K, Indra A, Kolarević S, Kračun-Kolarević M, Leopold M, Steinbacher S, Schachner I, Campostrini L, Risslegger A, Farnleitner AH, Kolm C, Kirschner AKT. First report on the occurrence of Vibrio cholerae nonO1/nonO139 in natural and artificial lakes and ponds in Serbia: evidence for a long-distance transfer of strains and the presence of Vibrio paracholerae. Environ Microbiol Rep. 2023;15:142–52.PubMedPubMedCentral
82.
Zurück zum Zitat Bliem R, Reischer G, Linke R, Farnleitner A, Kirschner AKT. Spatiotemporal dynamics of Vibrio cholerae in turbid alkaline lakes as determined by quantitative PCR. Appl Environ Microbiol. 2018;84:e317–18.PubMedPubMedCentral Bliem R, Reischer G, Linke R, Farnleitner A, Kirschner AKT. Spatiotemporal dynamics of Vibrio cholerae in turbid alkaline lakes as determined by quantitative PCR. Appl Environ Microbiol. 2018;84:e317–18.PubMedPubMedCentral
83.
Zurück zum Zitat Bliem R, Schauer S, Plicka H, Obwaller A, Sommer R, Steinrigl A, Alam M, Reischer GH, Farnleitner AH, Kirschner A. A novel triplex quantitative pcr strategy for quantification of toxigenic and nontoxigenic Vibrio cholerae in aquatic environments. Appl Environ Microbiol. 2015;81:3077–85.PubMedPubMedCentral Bliem R, Schauer S, Plicka H, Obwaller A, Sommer R, Steinrigl A, Alam M, Reischer GH, Farnleitner AH, Kirschner A. A novel triplex quantitative pcr strategy for quantification of toxigenic and nontoxigenic Vibrio cholerae in aquatic environments. Appl Environ Microbiol. 2015;81:3077–85.PubMedPubMedCentral
84.
Zurück zum Zitat Reischer GH, Haider JM, Sommer R, Stadler H, Keiblinger KM, Hornek R, Zerobin W, Mach RL, Farnleitner AH. Quantitative microbial faecal source tracking with sampling guided by hydrological catchment dynamics. Environ Microbiol. 2008;10:2598–608.PubMedPubMedCentral Reischer GH, Haider JM, Sommer R, Stadler H, Keiblinger KM, Hornek R, Zerobin W, Mach RL, Farnleitner AH. Quantitative microbial faecal source tracking with sampling guided by hydrological catchment dynamics. Environ Microbiol. 2008;10:2598–608.PubMedPubMedCentral
85.
Zurück zum Zitat Nandi B, Nandy RK, Mukhopadhyay S, Nair GB, Shimada T, Ghose AC. Rapid method for species-specific identification of Vibrio cholerae using primers targeted to the gene of outer membrane protein OmpW. J Clin Microbiol. 2000;38:4145–51.PubMedPubMedCentral Nandi B, Nandy RK, Mukhopadhyay S, Nair GB, Shimada T, Ghose AC. Rapid method for species-specific identification of Vibrio cholerae using primers targeted to the gene of outer membrane protein OmpW. J Clin Microbiol. 2000;38:4145–51.PubMedPubMedCentral
86.
Zurück zum Zitat Schauer S, Sommer R, Farnleitner AH, Kirschner AKT. Rapid and sensitive quantification of Vibrio cholerae and vibrio mimicus cells in water samples by use of catalyzed reporter deposition fluorescence in situ hybridization combined with solid-phase cytometry. Appl Environ Microbiol. 2012;78:7369–75.PubMedPubMedCentral Schauer S, Sommer R, Farnleitner AH, Kirschner AKT. Rapid and sensitive quantification of Vibrio cholerae and vibrio mimicus cells in water samples by use of catalyzed reporter deposition fluorescence in situ hybridization combined with solid-phase cytometry. Appl Environ Microbiol. 2012;78:7369–75.PubMedPubMedCentral
88.
Zurück zum Zitat Dickinson G, Lim KY, Jiang SC. Quantitative microbial risk assessment of pathogenic vibrios in marine recreational waters of southern california. Appl Environ Microbiol. 2013;79:294–302.PubMedPubMedCentral Dickinson G, Lim KY, Jiang SC. Quantitative microbial risk assessment of pathogenic vibrios in marine recreational waters of southern california. Appl Environ Microbiol. 2013;79:294–302.PubMedPubMedCentral
89.
Zurück zum Zitat Sunger N, Haas CN. Quantitative microbial risk assessment for recreational exposure to water bodies in Philadelphia. Water Environ Res. 2015;87:211–22.PubMed Sunger N, Haas CN. Quantitative microbial risk assessment for recreational exposure to water bodies in Philadelphia. Water Environ Res. 2015;87:211–22.PubMed
90.
Zurück zum Zitat Cohen MB, Giannella RA, Losonsky GA, Lang DR, Parker S, Hawkins JA, Gunther C, Schiff GA. Validation and characterization of a human volunteer challenge model for cholera by using frozen bacteria of the new Vibrio cholerae epidemic serotype, O139. Infect Immun. 1999;67:6346–9.PubMedPubMedCentral Cohen MB, Giannella RA, Losonsky GA, Lang DR, Parker S, Hawkins JA, Gunther C, Schiff GA. Validation and characterization of a human volunteer challenge model for cholera by using frozen bacteria of the new Vibrio cholerae epidemic serotype, O139. Infect Immun. 1999;67:6346–9.PubMedPubMedCentral
91.
Zurück zum Zitat Sack DA, Tacket CO, Cohen MB, Sack RB, Losonsky GA, Shimko J, Nataro JP, Edelman R, Levine MM, Giannella RA, Schiff G, Lang D. Validation of a volunteer model of cholera with frozen bacteria as the challenge. Infect Immun. 1998;66:1968–72.PubMedPubMedCentral Sack DA, Tacket CO, Cohen MB, Sack RB, Losonsky GA, Shimko J, Nataro JP, Edelman R, Levine MM, Giannella RA, Schiff G, Lang D. Validation of a volunteer model of cholera with frozen bacteria as the challenge. Infect Immun. 1998;66:1968–72.PubMedPubMedCentral
92.
Zurück zum Zitat Morris JG Jr., Takeda T, Tall BD, Losonsky GA, Bhattacharya SK, Forrest BD, Kay BA, Nishibuchi M. Experimental non‑O group 1 Vibrio cholerae gastroenteritis in humans. J Clin Invest. 1990;85:697–705.PubMedPubMedCentral Morris JG Jr., Takeda T, Tall BD, Losonsky GA, Bhattacharya SK, Forrest BD, Kay BA, Nishibuchi M. Experimental non‑O group 1 Vibrio cholerae gastroenteritis in humans. J Clin Invest. 1990;85:697–705.PubMedPubMedCentral
93.
Zurück zum Zitat Roser DJ, van den Akker B, Boase S, Haas CN, Ashbolt NJ, Rice SA. Pseudomonas aeruginosa dose response and bathing water infection. Epidemiol Infect. 2014;142:449–62.PubMed Roser DJ, van den Akker B, Boase S, Haas CN, Ashbolt NJ, Rice SA. Pseudomonas aeruginosa dose response and bathing water infection. Epidemiol Infect. 2014;142:449–62.PubMed
94.
Zurück zum Zitat Trucksis M, Galen JE, Michalski J, Fasano A, Kaper JB. Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette. Proc Natl Acad Sci U S A. 1993;90:5267–71.PubMedPubMedCentral Trucksis M, Galen JE, Michalski J, Fasano A, Kaper JB. Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette. Proc Natl Acad Sci U S A. 1993;90:5267–71.PubMedPubMedCentral
95.
Zurück zum Zitat Kaper JB, Srivastava BS. Genetics of cholera toxin. Indian J Med Res. 1992;95:163–7.PubMed Kaper JB, Srivastava BS. Genetics of cholera toxin. Indian J Med Res. 1992;95:163–7.PubMed
96.
Zurück zum Zitat Di Pierro M, Lu R, Uzzau S, Wang W, Margaretten K, Pazzani C, Maimone F, Fasano A. Zonula occludens toxin structure-function analysis. Identification of the fragment biologically active on tight junctions and of the zonulin receptor binding domain. J Biol Chem. 2001;276:19160–5.PubMed Di Pierro M, Lu R, Uzzau S, Wang W, Margaretten K, Pazzani C, Maimone F, Fasano A. Zonula occludens toxin structure-function analysis. Identification of the fragment biologically active on tight junctions and of the zonulin receptor binding domain. J Biol Chem. 2001;276:19160–5.PubMed
97.
Zurück zum Zitat Jørgensen R, Purdy AE, Fieldhouse RJ, Kimber MS, Bartlett DH, Merrill AR. Cholix toxin, a novel ADP-ribosylating factor from Vibrio cholerae. J Biol Chem. 2008;283:10671–8.PubMed Jørgensen R, Purdy AE, Fieldhouse RJ, Kimber MS, Bartlett DH, Merrill AR. Cholix toxin, a novel ADP-ribosylating factor from Vibrio cholerae. J Biol Chem. 2008;283:10671–8.PubMed
98.
Zurück zum Zitat Manning PA, Brown MH, Heuzenroeder MW. Cloning of the structural gene (hly) for the haemolysin of Vibrio cholerae El Tor strain 017. Gene. 1984;31:225–31.PubMed Manning PA, Brown MH, Heuzenroeder MW. Cloning of the structural gene (hly) for the haemolysin of Vibrio cholerae El Tor strain 017. Gene. 1984;31:225–31.PubMed
99.
Zurück zum Zitat Corkery DP, Nadeem A, Aung KM, Hassan A, Liu T, Cervantes-Rivera R, Lystad AH, Wang H, Persson K, Puhar A, Simonsen A, Uhlin BE, Wai SN, Wu YW. Vibrio cholerae cytotoxin MakA induces noncanonical autophagy resulting in the spatial inhibition of canonical autophagy. J Cell Sci. 2021;134:jcs252015.PubMed Corkery DP, Nadeem A, Aung KM, Hassan A, Liu T, Cervantes-Rivera R, Lystad AH, Wang H, Persson K, Puhar A, Simonsen A, Uhlin BE, Wai SN, Wu YW. Vibrio cholerae cytotoxin MakA induces noncanonical autophagy resulting in the spatial inhibition of canonical autophagy. J Cell Sci. 2021;134:jcs252015.PubMed
100.
Zurück zum Zitat Jonson G, Holmgren J, Svennerholm AM. Identification of a mannose-binding pilus on Vibrio cholerae El Tor. Microb Pathog. 1991;11:433–41.PubMed Jonson G, Holmgren J, Svennerholm AM. Identification of a mannose-binding pilus on Vibrio cholerae El Tor. Microb Pathog. 1991;11:433–41.PubMed
101.
Zurück zum Zitat Sperandio V, Girón JA, Silveira WD, Kaper JB. The OmpU outer membrane protein, a potential adherence factor of Vibrio cholerae. Infect Immun. 1995;63:4433–8.PubMedPubMedCentral Sperandio V, Girón JA, Silveira WD, Kaper JB. The OmpU outer membrane protein, a potential adherence factor of Vibrio cholerae. Infect Immun. 1995;63:4433–8.PubMedPubMedCentral
102.
Zurück zum Zitat Li CC, Crawford JA, DiRita VJ, Kaper JB. Molecular cloning and transcriptional regulation of ompT, a ToxR-repressed gene in Vibrio cholerae. Mol Microbiol. 2000;35:189–203.PubMed Li CC, Crawford JA, DiRita VJ, Kaper JB. Molecular cloning and transcriptional regulation of ompT, a ToxR-repressed gene in Vibrio cholerae. Mol Microbiol. 2000;35:189–203.PubMed
103.
Zurück zum Zitat Lin W, Fullner KJ, Clayton R, Sexton JA, Rogers MB, Calia KE, Calderwood SB, Fraser C, Mekalanos JJ. Identification of a vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage. Proc Natl Acad Sci U S A. 1999;96:1071–6.PubMedPubMedCentral Lin W, Fullner KJ, Clayton R, Sexton JA, Rogers MB, Calia KE, Calderwood SB, Fraser C, Mekalanos JJ. Identification of a vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage. Proc Natl Acad Sci U S A. 1999;96:1071–6.PubMedPubMedCentral
104.
Zurück zum Zitat Sarkar B, Bhattacharya T, Ramamurthy T, Shimada T, Takeda Y, Balakrish Nair G. Preferential association of the heat-stable enterotoxin gene (stn) with environmental strains of Vibrio cholerae belonging to the O14 serogroup. Epidemiol Infect. 2002;129:245–51.PubMedPubMedCentral Sarkar B, Bhattacharya T, Ramamurthy T, Shimada T, Takeda Y, Balakrish Nair G. Preferential association of the heat-stable enterotoxin gene (stn) with environmental strains of Vibrio cholerae belonging to the O14 serogroup. Epidemiol Infect. 2002;129:245–51.PubMedPubMedCentral
105.
Zurück zum Zitat Provenzano D, Schuhmacher DA, Barker JL, Klose KE. The virulence regulatory protein ToxR mediates enhanced bile resistance in Vibrio cholerae and other pathogenic Vibrio species. Infect Immun. 2000;68:1491–7.PubMedPubMedCentral Provenzano D, Schuhmacher DA, Barker JL, Klose KE. The virulence regulatory protein ToxR mediates enhanced bile resistance in Vibrio cholerae and other pathogenic Vibrio species. Infect Immun. 2000;68:1491–7.PubMedPubMedCentral
106.
Zurück zum Zitat Weber GG, Klose KE. The complexity of ToxT-dependent transcription in Vibrio cholerae. Indian J Med Res. 2011;133:201–6.PubMedPubMedCentral Weber GG, Klose KE. The complexity of ToxT-dependent transcription in Vibrio cholerae. Indian J Med Res. 2011;133:201–6.PubMedPubMedCentral
107.
Zurück zum Zitat Tam VC, Serruto D, Dziejman M, Brieher W, Mekalanos JJ. A type III secretion system in Vibrio cholerae translocates a formin/spire hybrid-like actin nucleator to promote intestinal colonization. Cell Host Microbe. 2007;1:95–107.PubMed Tam VC, Serruto D, Dziejman M, Brieher W, Mekalanos JJ. A type III secretion system in Vibrio cholerae translocates a formin/spire hybrid-like actin nucleator to promote intestinal colonization. Cell Host Microbe. 2007;1:95–107.PubMed
108.
Zurück zum Zitat Pukatzki S, Ma AT, Revel AT, Sturtevant D, Mekalanos JJ. Type VI secretion system translocates a phage tail spike-like protein into target cells where it cross-links actin. Proc Natl Acad Sci U S A. 2007;104:15508–13.PubMedPubMedCentral Pukatzki S, Ma AT, Revel AT, Sturtevant D, Mekalanos JJ. Type VI secretion system translocates a phage tail spike-like protein into target cells where it cross-links actin. Proc Natl Acad Sci U S A. 2007;104:15508–13.PubMedPubMedCentral
Metadaten
Titel
Vibrio cholerae—An emerging pathogen in Austrian bathing waters?
verfasst von
Carmen Rehm
Claudia Kolm
Sonja Pleininger
Florian Heger
Alexander Indra
Georg H. Reischer
Andreas A. H. Farnleitner
Alexander K. T. Kirschner
Publikationsdatum
02.08.2023
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 21-22/2023
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-023-02241-0

Weitere Artikel der Ausgabe 21-22/2023

Wiener klinische Wochenschrift 21-22/2023 Zur Ausgabe

MUW researcher of the month

MUW researcher of the month